Wolverine Trading
ITCI

Wolverine Trading’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Wolverine Trading’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,757
Closed -$227K – 5988
2024
Q3 		$202K Sell
2,757
-340
-11% -$25.6K ﹤0.01% 4086
2024
Q2 		$212K Sell
3,097
-1,420
-31% -$98.5K ﹤0.01% 3794
2024
Q1 		$313K Buy
+4,517
New +$310K ﹤0.01% 3310
2023
Q2 		– Sell
-8,602
Closed -$482K – 5111
2023
Q1 		$482K Buy
+8,602
New +$416K ﹤0.01% 2538
2022
Q1 		– Sell
-5,445
Closed -$283K – 6670
2021
Q4 		$284K Sell
5,445
-2,645
-33% -$111K ﹤0.01% 4227
2021
Q3 		$290K Buy
+8,090
New +$281K ﹤0.01% 4766
2020
Q4 		– Sell
-8,656
Closed -$227K – 5615
2020
Q3 		$221K Sell
8,656
-3,690
-30% -$84.2K ﹤0.01% 3763
2020
Q2 		$311K Buy
+12,346
New +$250K ﹤0.01% 3299
2020
Q1 		– Sell
-16,935
Closed -$368K – 5447
2019
Q4 		$570K Buy
+16,935
New +$203K ﹤0.01% 2953
2019
Q3 		– Sell
-16,816
Closed -$161K – 5168
2019
Q2 		$218K Sell
16,816
-884
-5% -$11.3K ﹤0.01% 3628
2019
Q1 		$216K Buy
17,700
+1,676
+10% +$21.4K ﹤0.01% 3737
2018
Q4 		$181K Sell
16,024
-18,578
-54% -$300K ﹤0.01% 3746
2018
Q3 		$751K Buy
34,602
+23,233
+204% +$486K ﹤0.01% 2653
2018
Q2 		$239K Hold
11,369
– – ﹤0.01% 4124
2018
Q1 		$239K Buy
11,369
+1,055
+10% +$20.6K ﹤0.01% 4124
2017
Q4 		$149K Buy
+10,314
New +$159K ﹤0.01% 4310
2016
Q4 		– Sell
-32,106
Closed -$453K – 5307
2016
Q3 		$495K Buy
+32,106
New +$1.3M ﹤0.01% 2579

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Wolverine Trading's ITCI Position: Q4 2024 in Review

Wolverine Trading sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2024, closing a stake of 2,757 shares — an estimated $227K sold.

Wolverine Trading first reported a position in ITCI in Q3 2016 and held it in 17 quarters. The position peaked at $751K in Q3 2018. 387 funds tracked by Wall St. Rank hold ITCI as of Q4 2024.

  • Wolverine Trading reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2024 after selling out during the quarter.
  • Wolverine Trading sold 2,757 Intra-Cellular Therapies Inc. shares in Q4 2024, an estimated $227K.
  • Wolverine Trading first reported a position in Intra-Cellular Therapies Inc. in Q3 2016 and held it in 17 quarters.
  • Wolverine Trading's Intra-Cellular Therapies Inc. position peaked at $751K in Q3 2018.
  • 387 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.